Lung cancer Flashcards
Pathogenesis of lung cancer: recall the pathogenesis of lung cancer and summarise risk factors Lung tumours: explain the local and systemic complications of lung tumours Histopathology of lung cancer: explain the common types of lung cancer, their biological behavior, prognosis and treatment Investigation of lung cancer: explain the modalities by which lung cancer can be diagnosed Staging of lung cancer: explain the macroscopic appearance of lung tumours and recall pathological parameters us
What is the epidemiology of lung cancer: Numbers? Proportion of all cancers? Survival time? Gender? Trend?
40,000 deaths per year in the UK. 25% of all cancer deaths. 5-year survival = 5.5%. Men at lifetime risk of 1 in 13, and women are at 1 in 23. Increased incidence in the developing world. But declining in developed world – has been since 1960s.
What are the major causes of lung cancer? (x4)
Smoking (including passive smoking – spouses of smokers have higher incidence too), asbestos, radiation (radon exposure, therapeutic radiation), genetic predisposition (although familial lung cancers are rare).
What is mutational compensation in relation to smoking?
Smoking damages the p53 genes, preventing cells from undergoing apoptosis and arrest, to allow them to become cancerous.
What is the effect of smoking cessation on lung cancer risk?
Quitting at any age with decrease risk.
What are the clinical features of lung cancer? Problem with clinical features? (x2)
Haemoptysis (coughing blood). Unexplained or persistent: cough, chest/shoulder pain, chest signs, dyspnoea, hoarseness, finger clubbing. PROBLEMS: There are not many! Coughing, hoarseness and breathlessness are normal things for smokers and even non-smokers, so cancer is not obvious.
What is clubbing defined as?
Angle at the nail is more than 180 degrees.
What are the two lung cancer types? How are cancers further categorised? (x2) Significance of identifying exact cancer?
Non-small cell cancer, and small cell lung cancer. FURTHER CATEGORISATION – based on molecular finger print of tumour cells, mutations (sub-group) and cell type. SIGNIFICANCE: Some sub-groups have more effective treatments, so identifying mutations can help if it is very treatable. IMMUNOPATHOLOGY important!
What is the difference in malignancy of small and non-small cell cancer?
Small cell cancer is highly malignant, with shorted doubling time and earlier metastases.
What are non-small cell lung cancers divided into? (x3)
Adenocarcinomas, squamous cell cancer, large cell cancer.
How are lung cancers staged?
TNM staging: Tumour (T1-4 based on size – 4 is the biggest), Nodes (N0-3), Metastasis (M0-1). Invasion of the chest wall or major vessels automatically upgrades cancer to at least T3.
What does cancer staging tell us?
Prognosis and operability.
What is the significance of lymph node sampling for lung cancer?
Sampling lymph nodes near the lung cancer tumour allows for staging AND diagnosis. So can save time doing different tests to establish both.
How are lymph nodes taken for sampling?
Ultrasound is used to see the nodes in real-time. A needle is used to take a sample of the lymph nodes.
What is the diagnostic strategy for lung cancer?
Typical symptoms submitted for CXR (of which there is a low threshold for testing). If abnormal, refer to Respiratory for CT scan of thorax for diagnosis and staging. Then, investigations with Pulmonary Function Test (PFTS), exercise tests and MRI of brain used to check for metastasis.
What is the FDG-PET-CT?
It is only imaging, and it not a tissue diagnosis. Additional specimen collection is required to confirm diagnosis. The test uses a radio-labelled glucose (FDG) actively taken up by rapidly dividing cancer cells. Lung and lymph node tissue should not take it up. So, if the glucose is taken up, it can be an indication of spread – actively seen on CT.
What is a trans-thoracic CT biopsy? Advantages (x2) and disadvantages (x2)? When is it used?
Needle inserted into lung tissue under CT guidance (so it’s REAL-TIME and HIGHLY SENSITIVE). Yet, risk of pneumothorax (25%-30%) and the sample size is small. Used when you cannot get a biopsy through bronchoscopy or lymph nodes i.e. when the tumour resides in peripheral bronchioles that bronchoscopy cannot access, and has not metastasised.